author
contribut
equal
work
background
recent
almost
studi
identifi
multipl
risk
factor
offer
practic
instrument
routin
use
predict
individu
surviv
human
infect
case
object
studi
creat
practic
instrument
use
predict
individu
surviv
probabl
patient
method
match
casecontrol
studi
ratio
perform
zhejiang
provinc
review
specif
factor
outcom
regard
patient
viru
infect
vi
determin
relationship
develop
nomogram
calcul
individu
surviv
probabl
tool
use
predict
individu
patient
probabl
surviv
base
result
obtain
multivari
cox
proport
hazard
regress
analysi
result
examin
patient
vi
enrol
studi
stepwis
select
appli
data
result
final
model
independ
predictor
includ
initi
pao
fio
ratio
mmhg
age
year
chronic
diseas
poor
hand
hygien
time
ill
onset
first
medic
visit
incub
period
day
peak
creactiv
protein
mgl
initi
bilater
lung
infect
concord
index
nomogram
confid
interv
ci
ci
train
valid
set
respect
indic
adequ
discriminatori
power
calibr
curv
surviv
show
optim
agreement
nomogram
predict
actual
observ
train
valid
set
respect
conclus
establish
valid
novel
nomogram
accur
predict
surviv
probabl
patient
vi
nomogram
serv
import
role
counsel
patient
vi
guid
treatment
decis
human
case
avian
influenza
viru
infect
vi
occur
annual
spring
winter
month
mainland
china
sinc
reach
laboratoryconfirm
case
death
octob
viru
infect
associ
sever
fatal
respiratori
diseas
human
laboratoryconfirm
human
infect
case
critic
ill
increas
number
infect
case
concomit
high
fatal
risk
caus
global
concern
regard
public
health
although
new
case
vi
report
china
april
vi
highest
risk
score
novel
influenza
virus
assess
influenza
risk
assess
tool
besid
ongo
monitor
clinicopatholog
molecular
featur
vi
recov
infect
human
poultri
market
live
poultri
bird
continu
epidemiolog
survey
clinic
sever
estim
infect
case
critic
develop
public
health
strategi
pandem
prepared
howev
avail
data
address
point
limit
previous
shown
clinician
make
diagnost
treatment
decis
base
sole
clinic
judgment
lack
predict
accuraci
regard
death
risk
human
infect
case
therefor
unabl
increas
surviv
probabl
case
accur
assess
surviv
probabl
would
help
tailor
treatment
human
infect
case
unfortun
vast
major
publish
studi
topic
focu
risk
factor
infect
case
fatal
though
previou
studi
establish
sever
model
base
predict
outcom
vi
show
certain
applic
valu
current
model
avail
predict
assess
surviv
human
infect
case
date
almost
studi
identifi
multipl
risk
factor
integr
comprehens
assess
patient
specif
surviv
probabl
human
vi
well
establish
varieti
studi
nomogram
model
algorithm
integr
predictor
identifi
practic
tool
prevent
intervent
addit
nomogram
accur
predict
estim
individu
risk
diseas
quantit
demonstr
person
probabl
predict
incid
diseas
outcom
better
evalu
predictor
associ
surviv
outcom
base
match
studi
ratio
retrospect
investig
sociodemograph
clinic
epidemiolog
data
laboratoryconfirm
case
vi
zhejiang
provinc
china
march
may
object
studi
determin
predictor
surviv
patient
creat
practic
instrument
base
result
obtain
multivari
cox
proport
hazard
model
use
predict
evalu
individu
surviv
probabl
patient
calcul
sampl
size
use
follow
formula
n
sampl
size
alpha
expect
signific
level
twotail
test
expect
power
twotail
test
z
statist
z
z
statist
confid
level
rnumber
control
subject
match
case
subject
p
exposur
case
group
p
probabl
exposur
control
group
p
estim
popul
preval
exposur
odd
ratio
odd
ratio
exposur
case
control
estim
popul
exposur
studi
investig
present
result
confid
interv
ci
z
z
r
p
addit
consid
loss
followup
particip
reject
rate
sampl
error
final
sampl
size
determin
train
set
valid
set
select
studi
use
comer
design
workflow
studi
summar
figur
two
separ
dataset
use
develop
valid
predict
tool
base
surviv
patient
data
institut
ie
first
affili
hospit
zhejiang
univers
school
medicin
n
use
train
data
set
deriv
surviv
patient
data
institut
ii
ie
design
hospit
includ
shaox
peopl
hospit
ningbo
second
hospit
first
hospit
jiax
provid
vi
treatment
zhejiang
provinc
n
use
independ
dataset
valid
predict
tool
quantit
surviv
featur
extract
human
infect
case
univari
analysi
includ
pearson
chisquar
test
independ
sampl
test
univari
cox
proport
hazard
regress
model
multivari
cox
proport
hazard
regress
model
appli
select
optim
independ
predictor
build
practic
instrument
predict
evalu
surviv
patient
vi
match
studi
ratio
conduct
zhejiang
provinc
patient
laboratoryconfirm
vi
enrol
retrospect
studi
march
may
constitut
studi
present
studi
case
select
vi
design
hospit
zhejiang
provinc
observ
studi
subject
classifi
die
ie
case
group
surviv
group
control
group
accord
ultim
outcom
case
select
studi
use
comer
principl
long
met
inclus
exclus
criteria
control
select
use
random
sampl
method
vi
design
hospit
subject
ultim
select
histori
vi
treatment
b
definit
treatment
outcom
c
could
follow
subject
exclud
patient
treat
b
treatment
outcom
could
obtain
c
subject
lost
followup
visit
miss
data
sever
figur
start
date
vi
defin
start
time
observ
studi
defin
patient
observ
end
date
end
date
studi
data
incid
death
surviv
incid
death
surviv
year
collect
march
may
collect
medic
record
patient
vi
zhejiang
provinc
surveil
databas
infecti
diseas
manag
china
center
diseas
control
prevent
cdc
provinci
cdc
confirm
patient
vi
ask
report
cdc
within
day
nation
monitor
system
infecti
diseas
staff
member
local
cdc
assign
collect
data
use
standard
questionnair
accord
field
investig
extract
data
regard
patient
clinic
epidemiolog
sociodemograph
featur
well
timetoev
date
prognos
way
data
collect
detailedli
describ
previou
studi
data
enter
duplic
electron
databas
retrospect
studi
laboratoryconfirm
case
vi
zhejiang
provinc
march
may
new
case
vi
report
zhejiang
provinc
decemb
exclud
human
infect
patient
accord
inclus
exclus
criteria
patient
train
set
n
extern
valid
set
n
analyz
respect
figur
definit
case
exposur
laboratori
examin
viru
detailedli
describ
elsewher
main
outcom
variabl
measur
incid
death
surviv
tabl
show
definit
variabl
studi
univari
analysi
perform
determin
factor
includ
patient
clinic
epidemiolog
demograph
featur
well
timetoev
date
prognos
associ
surviv
patient
vi
train
dataset
valid
dataset
research
divid
subject
two
group
base
death
surviv
infect
pearson
chisquar
test
use
categor
variabl
independ
sampl
ttest
continu
variabl
base
baselin
characterist
subject
includ
train
valid
set
laboratori
find
questionnair
variabl
analyz
use
hazard
ratio
hr
gener
univari
cox
proport
hazard
regress
subsequ
independ
predictor
associ
surviv
vi
evalu
use
hr
gener
multivari
cox
regress
model
variabl
p
valu
includ
multivari
cox
regress
analysi
use
backward
stepwis
method
base
minimum
statist
akaik
inform
criterion
variabl
p
valu
less
consid
statist
signific
multivari
cox
regress
model
includ
final
predict
model
nomogram
develop
base
patient
variabl
train
set
model
use
predict
individu
patient
surviv
probabl
base
result
multivari
cox
proport
hazard
regress
analysi
train
set
nomogram
develop
valid
nomogram
valid
includ
two
compon
first
intern
valid
clinic
nomogram
perform
use
concord
index
cindex
subject
nomogram
bootstrap
resampl
next
extern
valid
predict
surviv
patient
use
data
individu
valid
set
calibr
nomogram
probabl
surviv
patient
perform
compar
predict
probabl
surviv
observ
probabl
surviv
bia
correct
statist
analys
conduct
r
softwar
version
wwwrprojectorg
multivari
cox
proport
hazard
regress
model
creat
use
r
softwar
surviv
packag
nomogram
calibr
curv
plot
use
rm
packag
flow
diagram
summar
identifi
elig
patient
studi
particip
shown
figur
baselin
characterist
studi
popul
list
tabl
retrospect
studi
patient
vi
zhejiang
provinc
patient
train
set
extern
valid
set
n
analyz
respect
mean
age
ratio
male
femal
train
valid
set
respect
notabl
confirm
case
aggreg
hangzhou
citi
studi
popul
histori
chronic
diseas
chronic
diseas
includ
chronic
cardiovascular
diseas
ie
hypertens
coronari
heart
diseas
myocardiopathi
valvular
diseas
chronic
liver
diseas
ie
chronic
hepat
liver
cirrhosi
liver
tumor
chronic
metabol
diseas
ie
obes
diabet
fatti
liver
diseas
cancer
chronic
respiratori
diseas
ie
chronic
obstruct
pulmonari
diseas
chronic
bronchiti
rheumat
diseas
histori
surgeri
surgeri
includ
type
human
surgeri
ie
tumor
enucl
hand
hygien
refer
hand
hygien
practic
diseas
onset
antisept
hand
wash
antisept
hand
rub
surgic
hand
antisepsi
handwash
frequent
ie
contact
anim
meal
use
toilet
etc
hand
hygien
practic
includ
poor
hand
hygien
use
antisept
hand
wash
prep
alcohol
wash
hand
soap
water
deterg
contain
antisept
agent
wash
hand
frequent
contact
poultri
anim
elig
hand
hygien
like
use
antisept
handwash
prep
alcohol
wash
hand
soap
water
deterg
contain
antisept
agent
wash
hand
frequent
contact
poultri
anim
histori
smoke
smoke
defin
cigarett
per
day
histori
drink
drink
defin
drink
one
sit
least
per
week
patient
loss
follow
includ
cough
expector
fever
chest
distress
shiver
diarrhea
asthma
headach
pharyng
pain
abdomin
pain
chest
pain
muscl
ach
patient
treat
defin
patient
antivir
drug
therapi
cours
studi
refer
patient
could
investig
lost
patient
patient
refus
investig
cours
studi
random
sampl
method
ratio
pfr
mmhg
peak
creactiv
protein
crp
studi
first
stage
random
sampl
method
assign
number
n
element
subject
next
stage
pick
sampl
n
number
use
tabl
random
number
use
method
must
assur
number
chosen
differ
none
larger
n
number
select
individu
correspond
number
view
sampl
pfr
defin
ratio
arteri
oxygen
partial
pressur
fraction
inspir
oxygen
sea
level
normal
refer
valu
peak
crp
hospit
initi
white
blood
cell
wbc
count
l
includ
decreas
ie
wbc
count
increas
ie
wbc
count
normal
ie
wbc
count
wbc
tabl
summar
result
univari
analys
associ
individu
covari
surviv
influenza
seventeen
test
covari
significantli
associ
surviv
influenza
train
set
p
signific
covari
demograph
characterist
includ
age
age
year
retir
cd
phh
b
time
characterist
diagnosi
treatment
includ
amount
time
ill
onset
first
medic
visit
tiofmv
time
ill
onset
treatment
outcom
time
treat
outpati
clinic
time
treat
hospit
c
clinic
characterist
includ
initi
pao
fio
ratio
ipfr
mmhg
incub
period
ip
ip
day
peak
creactiv
protein
crp
mgl
increas
initi
neutrophil
percentag
inp
initi
bilater
lung
infect
ibli
peak
crp
inp
remain
covari
includ
gender
onset
time
incid
area
type
resid
educ
level
surgeri
smoke
drink
direct
contact
poultri
bird
visit
market
live
poultri
bird
sold
within
day
preced
ill
onset
time
ill
onset
hospit
time
ill
onset
oseltamivir
treatment
time
ill
onset
admiss
intens
care
unit
time
ill
onset
laboratori
confirm
time
ill
onset
report
cdc
first
symptom
count
bodi
temperatur
peak
initi
white
blood
cell
count
iwbcc
increas
iwbcc
decreas
iwbcc
decreas
initi
lymphocyt
percentag
ilp
decreas
initi
hemoglobin
valu
decreas
initi
blood
platelet
count
ilp
initi
hemoglobin
valu
initi
blood
platelet
count
associ
surviv
influenza
p
explor
possibl
predictor
surviv
influenza
perform
multivari
cox
proport
hazard
regress
analysi
analysi
show
age
year
cd
phh
tiofmv
ip
day
ipfr
mmhg
peak
crp
mgl
ibli
significantli
link
surviv
patient
model
also
indic
independ
variabl
ipfr
mmhg
strongest
impact
factor
surviv
influenza
hr
ci
p
tabl
find
use
creat
practic
clinic
nomogram
predict
surviv
probabl
influenza
figur
nomogram
develop
assess
surviv
use
signific
factor
patient
data
train
set
variabl
train
set
ipfr
mmhg
ibli
peak
crp
mgl
tiofmv
ip
day
cd
phh
age
year
tabl
possibl
creat
nomogram
predict
probabl
surviv
influenza
figur
top
row
nomogram
correspond
gener
score
variabl
list
left
correspond
row
right
indic
possibl
descriptor
character
patient
variabl
perpendicular
line
toward
first
row
drawn
identifi
valu
action
perform
variabl
follow
talli
final
score
final
score
identifi
total
point
row
perpendicular
line
drawn
correspond
probabl
surviv
influenza
intern
valid
use
bootstrap
techniqu
cindex
nomogram
ci
ci
train
valid
set
respect
indic
adequ
discriminatori
power
calibr
plot
also
perform
separ
use
train
extern
valid
set
shown
figur
calibr
plot
show
predict
probabl
surviv
influenza
correspond
close
actual
probabl
surviv
influenza
estim
train
set
figur
illustr
nomogram
appear
well
calibr
strong
correl
predict
observ
outcom
across
spectrum
predict
extern
valid
set
make
easier
interpret
result
repres
final
reduc
model
nomogram
use
calcul
prognost
score
estim
surviv
influenza
individu
patient
figur
nomogram
produc
follow
mathemat
predict
model
presenc
surviv
influenza
train
set
h
x
denot
probabl
surviv
patient
h
x
hazard
time
defin
start
point
individu
variabl
x
x
x
x
k
predict
h
socal
underli
hazard
time
predictor
variabl
x
x
k
record
time
zero
variabl
x
multipli
correspond
regress
coeffici
exp
stand
exponenti
function
eg
exp
e
underli
hazard
h
hazard
time
individu
whose
x
zero
predict
probabl
associ
factor
map
point
scale
presenc
level
predict
factor
associ
point
system
allow
sum
point
independ
predictor
total
point
accumul
variou
covari
correspond
predict
probabl
surviv
exampl
individu
characterist
year
age
older
cd
tiofmv
day
ip
day
ipfr
mmhg
peak
crp
mgl
ibli
see
tabl
vi
know
usual
present
sever
diseas
although
vi
treat
mortal
case
high
review
literatur
data
found
valid
prognost
model
surviv
infect
case
previou
studi
demonstr
central
compon
prevent
strategi
identif
individu
risk
develop
diseas
accur
predict
estim
prognosi
diseas
essenti
patient
counsel
treatment
decisionmak
admittedli
patient
interest
inquir
chanc
recoveri
probabl
surviv
accord
data
individu
case
unfortun
far
littl
attent
paid
develop
nomogram
comprehens
estim
patient
specif
probabl
surviv
clinic
practic
studi
perform
match
studi
explor
predictor
surviv
case
studi
figur
nomogram
individu
predict
probabl
surviv
influenza
abbrevi
phh
poor
hand
hygien
cd
chronic
diseas
ip
incub
period
tiofmv
time
ill
onset
first
medic
visit
day
crp
creactiv
protein
ibli
initi
bilater
lung
infect
ipfr
initi
ratio
identifi
independ
predictor
surviv
obtain
primari
patient
data
includ
sociodemograph
data
clinic
find
laboratori
data
epidemiolog
base
result
present
studi
establish
valid
robust
nomogram
provid
simpl
precis
person
predict
surviv
case
figur
find
may
provid
reliabl
evid
develop
prevent
control
strategi
vi
anticip
result
use
reduc
mortal
vi
design
clinic
intervent
improv
life
qualiti
patient
vi
current
studi
import
offer
import
featur
first
first
nomogram
predict
surviv
patient
collect
enough
risk
factor
allow
reliabl
predict
evalu
analys
second
valid
analysi
nomogram
whether
intern
ie
cindex
nomogram
train
valid
set
respect
extern
comprehens
model
produc
suffici
precis
satisfi
uniform
predict
surviv
vi
third
infect
case
enrol
studi
use
comer
principl
regardless
etiolog
demograph
thu
sampl
like
repres
gener
popul
zhejiang
provinc
anoth
import
aspect
appli
nomogram
simpl
conveni
economyfriendli
ie
accur
assess
made
use
eight
domin
predictor
surviv
among
patient
nomogram
model
compar
easi
use
assess
combin
variou
predictor
help
clinician
accur
predict
prognosi
individu
case
clinic
nomogram
may
demonstr
better
individu
identif
gener
regress
forecast
model
although
previou
report
suggest
logist
regress
model
use
evalu
death
risk
vi
may
accur
reflect
effect
variabl
prognost
fact
surviv
analysi
need
consid
impact
time
effect
specif
consid
assess
surviv
probabl
use
semiparametr
model
ie
cox
proport
hazard
model
maxim
wald
statist
interestingli
could
infer
signific
associ
exist
shorter
incub
period
greater
risk
death
among
human
case
gener
incub
period
durat
premonitori
symptom
shorter
respiratori
diseas
symptom
sever
mortal
rate
higher
rule
thumb
support
present
studi
find
associ
may
attribut
avian
influenza
viru
growth
characterist
receptor
usag
host
respons
lead
sever
cytopath
effect
likewis
phh
significantli
associ
surviv
patient
vi
research
indic
high
viral
load
associ
ill
sever
prognosi
might
origin
poor
hand
hygien
selfprotect
measur
contact
poultri
anim
improv
surviv
vi
vital
appropri
hand
hygien
practic
implement
suscept
popul
direct
contact
poultri
bird
furthermor
infer
phh
associ
nonlinear
effect
surviv
patient
figur
although
wors
surviv
among
patient
phh
previous
note
studi
better
defin
nonlinear
relat
phh
outcom
notabl
ipfr
use
clinic
predictor
vi
outcom
present
studi
though
diagnost
util
disput
clinic
work
accord
present
result
previou
studi
demonstr
pfr
essenti
indic
assess
acut
lung
injuri
acut
respiratori
distress
syndrom
patient
known
oxygen
transport
diffusionlimit
alveolu
pulmonari
capillari
patient
pulmonari
diseas
ie
pulmonari
fibrosi
sever
report
shown
pfr
respond
increas
divers
constant
oxygen
satur
indic
poorer
pulmonari
function
thu
reason
assum
pfr
may
use
clinic
set
indic
predict
pulmonari
function
statu
patient
vi
model
present
surviv
vi
associ
ipfr
less
equal
mmhg
see
tabl
find
preliminari
suggest
ipfr
would
seem
adequ
measur
pulmonari
dysfunct
patient
vi
addit
predictor
sever
predictor
select
base
multivari
cox
regress
analysi
includ
peak
crp
mgl
year
age
older
cd
tiofmv
ibli
predictor
strong
effect
surviv
therefor
includ
individu
nomogram
model
data
present
studi
also
quantit
authent
effect
predictor
surviv
brief
aggreg
independ
predictor
clinic
nomogram
model
comprehens
predict
patient
person
probabl
surviv
figur
importantli
best
way
interpret
appli
find
term
individu
factor
contribut
risk
paramet
modifi
improv
potenti
increas
surviv
patient
sinc
death
mechan
patient
still
unclear
find
algorithm
use
modifi
identifi
patient
risk
factor
effort
minim
mortal
term
find
identifi
predictor
surviv
may
impact
treatment
healthcar
surveil
case
studi
confirm
decreas
ipfr
defin
strong
predictor
surviv
patient
vi
implic
possibl
uppermost
treatment
strategi
improv
pulmonari
function
case
also
find
peak
crp
level
may
consid
particularli
import
factor
evalu
probabl
associ
surviv
case
accord
studi
conduct
gao
colleagu
crp
involv
deterior
observ
sever
influenza
infect
may
candid
molecul
immunotherapi
treatment
previou
studi
indic
crp
treatment
improv
prognosi
patient
vi
well
known
therapeut
measur
elect
select
treatment
measur
improv
crp
clinic
tool
may
abl
help
physician
solv
problem
moreov
nomogram
provid
inform
guid
clinician
decisionmak
regard
effect
intervent
strategi
patient
exampl
accord
algorithm
patient
found
high
risk
death
find
import
implic
develop
strategi
earli
intervent
highrisk
death
popul
patient
addit
find
cost
appli
nomogram
mainli
involv
develop
practic
tool
nomogram
ie
evalu
scale
incorpor
nomogram
treatment
inform
system
hospit
govern
depart
abl
afford
cost
expens
appli
tool
overal
nomogram
may
display
advanc
public
health
concept
predict
prevent
person
medicin
tool
deserv
explor
futur
research
clinic
public
health
consid
advantag
nomogram
suggest
govern
guid
support
foster
develop
tool
addit
treatment
scheme
case
includ
nomogram
formul
govern
studi
limit
first
nomogram
limit
retrospect
natur
data
could
suffer
recal
bia
failur
incorpor
recogn
prognost
paramet
eg
frequenc
intens
exposur
bacteri
coinfect
import
molecular
factor
eg
proinflammatori
cytokin
angiotensin
ii
second
effort
regard
prospect
data
collect
patient
followup
wider
geograph
recruit
incorpor
addit
factor
encourag
improv
tool
third
studi
larg
sampl
popul
necessari
confirm
model
despit
limit
know
limit
number
publish
data
surviv
patient
therefor
studi
could
contribut
inform
novel
concept
predict
prevent
person
medicin
surviv
patient
far
littl
done
enhanc
clinician
abil
properli
counsel
patient
individu
risk
prior
initi
treatment
infect
match
casecontrol
studi
construct
valid
novel
nomogram
base
statu
year
age
older
cd
phh
tiofmv
ip
day
ipfr
mmhg
peak
crp
mgl
ibli
accur
predict
probabl
surviv
among
patient
vi
conclus
nomogram
serv
import
role
counsel
patient
vi
guid
treatment
decis
consid
high
mortal
patient
high
medic
cost
patient
care
earli
identifi
atrisk
individu
earli
interven
onset
ill
reduc
high
mortal
econom
burden
attribut
diseas
abbrevi
vi
viru
infect
cdc
center
diseas
control
prevent
odd
ratio
ci
confid
interv
cindex
concord
index
phh
poor
hand
hygien
cd
chronic
diseas
tiofmv
time
ill
onset
first
medic
visit
ip
incub
period
crp
creactiv
protein
ipfr
initi
pao
fio
ratio
inp
initi
neutrophil
percentag
ibli
initi
bilater
lung
infect
iwbcc
initi
white
blood
cell
count
ilp
initi
lymphocyt
percentag
ivh
initi
valu
hemoglobin
ibpc
initi
blood
platelet
count
obtain
ethic
approv
carri
studi
institut
review
board
irb
hangzhou
center
diseas
control
prevent
hangzhou
china
medic
director
select
hospit
acknowledg
irb
deliv
permiss
start
data
collect
patient
rel
provid
written
inform
consent
research
carri
complianc
helsinki
declar
individu
inform
strictli
kept
confidenti
anonym
manuscript
publish
work
journal
risk
manag
healthcar
polici
intern
peerreview
open
access
journal
focus
aspect
public
health
polici
prevent
measur
promot
good
health
improv
morbid
mortal
popul
journal
welcom
submit
paper
cover
origin
research
basic
scienc
clinic
epidemiolog
studi
review
evalu
guidelin
expert
opinion
commentari
case
report
extend
report
manuscript
manag
system
complet
onlin
includ
quick
fair
peerreview
system
easi
use
visit
http
wwwdovepresscomtestimonialsphp
read
real
quot
publish
author
submit
manuscript
http
wwwdovepresscomriskmanagementandhealthcarepolicyjourn
